• Skip to primary navigation
  • Skip to main content
SRI logo
  • About
    • Press room
  • Expertise
    • Advanced imaging systems
    • Artificial intelligence
    • Biomedical R&D services
    • Biomedical sciences
    • Computer vision
    • Cyber & formal methods
    • Education and learning
    • Innovation strategy and policy
    • National security
    • Ocean & space
    • Quantum
    • QED-C
    • Robotics, sensors & devices
    • Speech & natural language
    • Video test & measurement
  • Ventures
  • NSIC
  • Careers
  • Contact
  • 日本支社
Search
Close
Bios September 8, 2021

Shravan K Mutyam

Research Associate, Formulation R&D, Applied Research

Shravan K Mutyam researches pharmaceutical excipients and their functionalities to develop pre-clinical and clinical pharmaceutical formulations. He is involved in formulation development efforts of several drug candidates including NCEs for animal toxicology, PK-PD and bioavailability studies – specifically molecules with poor solubility and permeability by developing enabling formulations.

Mutyam designs and assists in development of preclinical formulations from lab scale to Phase I clinical formulations. He has worked with formulation development of diverse dosage forms including oral solid dosage forms (tablets and capsules), immediate release/modified release dosage forms, lipid-based formulations, maltiparticulate bead capsule formulations, solutions, suspensions, microspheres, powder in bottle, vaccines, emulsions, spray dried dispersions (SDD), self-emulsifying drug delivery systems (SEDDS), parenteral and transdermal formulations.

Mutyam received his M.S. in Chemistry from Lamar University, Beaumont, Texas and holds a certificate in Project Management (Life Sciences and Drug Development) from University of California, Berkeley Ext. He has a bachelor’s degree in pharmaceutical sciences (bachelor of pharmacy) from Osmania University, Hyderabad, India and a diploma in pharmacy from Govt. Polytechnic, Hyderabad, India.

Recent publications

more +

Formulation Approaches to Improving the Delivery of an Antiviral Drug with Activity against Seasonal Flu (3/1/2015) - The main objective of the present study was to develop formulations of noscapine hydrochloride hydrate with enhanced solubility and bioavailability…
Tablet formulation of an active pharmaceutical ingredient with a sticking and filming problem: direct compression and dry granulation evaluations (2/1/2015) - Direct compression and dry granulation tableting techniques were evaluated using factorial experimental design.
Permeability Enhancing Lipid-Based Co-Solvent and SEDDS Formulations of SQ641, an Antimycobacterial Agent (6/1/2014) - Abstract Context: Tuberculosis (TB) is a common and often deadly infectious disease caused by strains of Mycobacteria. Development of new…

How can we help?

Once you hit send…

We’ll match your inquiry to the person who can best help you.

Expect a response within 48 hours.

Career call to action image

Make your own mark.

Search jobs

Our work

Case studies

Publications

Timeline of innovation

Areas of expertise

Institute

Leadership

Press room

Media inquiries

Compliance

Careers

Job listings

Contact

SRI Ventures

Our locations

Headquarters

333 Ravenswood Ave
Menlo Park, CA 94025 USA

+1 (650) 859-2000

Subscribe to our newsletter


日本支社
SRI International
  • Contact us
  • Privacy Policy
  • Cookies
  • DMCA
  • Copyright © 2022 SRI International